Contact us at (866) 265-5575 or sales@realhealthdata.com

Publications

 

 

Arm yourself with the right tools and knowledge.

Get a copy of our EPI Study White Paper.

REQUEST YOUR COPY

RealHealth Data EPI White paper
  • ISPOR – Utilization Patterns of the First US Biosimilar, Filgrastim-Sndz

    Utilization Patterns of the First US Biosimilar, Filgrastim-Sndz Karen E. Smoyer1, Bríain Ó Hartaigh2 1Curo, a Division of Envision...

    RealHealthData
  • ISPOR – Clinico Genomic Evidence Generation

    Use of Medical Transcription Data for Real World Clinicogenomic Evidence Generation for Mental Health Disorders In U.S. Mehta J1,...

    RealHealthData
  • ISPOR

    Uptake of the First US Biosimilar: Filgrastim-sndz Utilization Observed in a Medical Transcription Database of Patient Office Visits Karen...

    RealHealthData
  • ISPOR EU

    Uptake of Filgrastim ‘Biosimilars’ in the United States: Analysis of a Medical Transcription Database of Patient O.ce Visits Smoyer...

    RealHealthData
  • ISPOR – RA Switching

    Evaluation of Disease Activity in Patients Diagnosed With Rheumatoid Arthritis: How Often and to What Detail Are Assessments Documented...

    RealHealthData
  • ISPOR – RA Guidelines

    Evaluation of Disease Activity in Patients Diagnosed With Rheumatoid Arthritis: How Often and to What Detail Are Assessments Documented?...

    RealHealthData

CLINICAL TRIAL PODCAST | CONVERSATIONS WITH CLINICAL RESEARCH EXPERTS

Real World Data in Clinical Trials with Manuel Prado

Listen now